For personal use only

ASX Release

26 November 2021

Amended Constitution

Melbourne, Australia; 26 November 2021

An amendment to the Constitution of Acrux Limited (ASX:ACR, " " or the " ") was approved by a poll of shareholders at the Company's AnnualAcruxGeneral MeetingCompanyheld on 23 November.

Clause 7.3 has been amended to increase the limit on the number of registered joint holders of a share that the Company can record in its register of members from 3 to 4.

The amended constitution is attached to this announcement.

Authorised for release by the Board of Acrux Limited.

For more information, please contact:

General enquiries

Michael Kotsanis

Acrux Limited

P:CEO+ 61& Managing3 8379 0100Director

E: michael.kotsanis@acrux.com.au

bout Acrux

Acrux (ASX: ACR) is a pharmaceutical company dedicated to developing and commercialising topical pharmaceuticals. Incorporated in 1998 and using in house facilities and capabilities, Acrux has successfully developed and commercialised through licensees a number of topically applied pharmaceutical products in the US and Europe. Acrux is developing of a range of generic products for the US market by leveraging its on-site laboratories, GMP manufacturing suite, clinical and commercial experience to bring affordable products to market. Acrux encourages collaboration and is well positioned to discuss partnering and product development.

For further information on Acrux, visit www.acrux.com.au

For personal use only

Constitution

Acrux Limited ACN 082 001 152

For personal use only

2

Constitution of Acrux Limited

  1. Defined terms & interpretation
  2. Pooled development fund
  3. Rights
  4. Issue of Shares
  5. Commission and brokerage
  6. Trusts not recognised
  7. Joint holders
  8. Share certificates
  9. Class meetings
  10. Non-marketableparcels
  11. General
  12. Instalments and amounts which become payable
  13. Interest and expenses
  14. Recovery of amounts due
  15. Differentiation
  16. Payment of calls in advance
  17. Lien
  18. Lien sale
  19. Forfeiture notice
  20. Forfeiture
  21. Liability of former Member
  22. Disposal of Shares
  23. General
  24. Transfer procedure
  25. Right to refuse registration
  26. Title on death
  27. Entitlement to transmission
  28. Consolidation or division

1

3

3

3

4

4

4

4

5

5

7

7

7

7

8

8

8

9

9

10

10

10

11

12

12

13

13

14

For personal use only

3

  1. Powers of attorney
  2. Calling general meeting
  3. Notice
  4. Business
  5. Member
  6. Quorum
  7. Chairperson
  8. General conduct
  9. Adjournment
  10. Decisions
  11. Taking a poll
  12. Casting vote of chairperson
  13. Admission to general meetings
  14. Auditor's right to be heard
  15. Entitlement to vote
  16. Unpaid calls
  17. Joint holders
  18. Objections
  19. Votes by proxy
  20. Document appointing proxy
  21. Proxy in blank
  22. Lodgment of proxy
  23. Validity
  24. Representatives of bodies corporate
  25. Number of Directors
  26. Qualification
  27. Power to remove and appoint
  28. Additional and casual Directors
  29. Filling vacated office
  30. Retirement by rotation

14

14

14

15

16

16

16

17

17

17

18

18

18

19

19

19

20

20

20

21

21

21

22

22

22

23

23

23

24

24

For personal use only

4

  1. Nomination of Director
  2. Vacation of office
  3. Remuneration of Non-Executive Directors
  4. Remuneration of Executive Directors
  5. Retirement benefits
  6. Directors to manage Company
  7. Directors' meetings
  8. Decisions
  9. Directors' interests
  10. Alternate Directors
  11. Remaining Directors
  12. Chairperson
  13. Delegation
  14. Written resolutions
  15. Validity of acts of Directors
  16. Minutes
  17. Appointment
  18. Powers of Executive Directors
  19. General
  20. Appointment of attorneys and agents
  21. Secretary
  22. Common Seal
  23. Duplicate Seal
  24. Share Seal
  25. Times for inspection
  26. Dividends
  27. Amend resolution to pay dividend
  28. No interest
  29. Reserves
  30. Dividend entitlement

24

24

25

26

26

26

26

27

27

28

29

29

29

30

30

30

31

31

32

32

33

33

33

33

34

34

34

34

34

35

This is an excerpt of the original content. To continue reading it, access the original document here.

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

Acrux Limited published this content on 26 November 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 26 November 2021 01:19:04 UTC.